These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33907889)

  • 21. The use of muscle strength assessed with handheld dynamometers as a non-invasive biological marker in myotonic dystrophy type 1 patients: a multicenter study.
    Hébert LJ; Remec JF; Saulnier J; Vial C; Puymirat J
    BMC Musculoskelet Disord; 2010 Apr; 11():72. PubMed ID: 20398425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MRI of trunk muscles and motor and respiratory function in patients with myotonic dystrophy type 1.
    Solbakken G; Bjørnarå B; Kirkhus E; Nguyen B; Hansen G; Frich JC; Ørstavik K
    BMC Neurol; 2019 Jun; 19(1):135. PubMed ID: 31216995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial.
    Okkersen K; Jimenez-Moreno C; Wenninger S; Daidj F; Glennon J; Cumming S; Littleford R; Monckton DG; Lochmüller H; Catt M; Faber CG; Hapca A; Donnan PT; Gorman G; Bassez G; Schoser B; Knoop H; Treweek S; van Engelen BGM;
    Lancet Neurol; 2018 Aug; 17(8):671-680. PubMed ID: 29934199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing upper extremity capacity as a potential indicator of needs related to household activities for rehabilitation services in people with myotonic dystrophy type 1.
    Raymond K; Auger LP; Cormier MF; Vachon C; St-Onge S; Mathieu J; Noreau L; Gagnon C
    Neuromuscul Disord; 2015 Jun; 25(6):522-9. PubMed ID: 25953319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA).
    DiPaolo G; Jimenez-Moreno C; Nikolenko N; Atalaia A; Monckton DG; Guglieri M; Lochmüller H
    J Neurol; 2017 Apr; 264(4):701-708. PubMed ID: 28168524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isokinetic strength and degeneration of lower extremity muscles in patients with myotonic dystrophy; an MRI study.
    Steenkjaer CH; Mencagli RA; Vaeggemose M; Andersen H
    Neuromuscul Disord; 2021 Mar; 31(3):198-211. PubMed ID: 33568272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body composition and clinical outcome measures in patients with myotonic dystrophy type 1.
    Sedehizadeh S; Brook JD; Maddison P
    Neuromuscul Disord; 2017 Mar; 27(3):286-289. PubMed ID: 28082208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the functional capacity outcome measures for myotonic dystrophy.
    Jimenez-Moreno AC; Nikolenko N; Kierkegaard M; Blain AP; Newman J; Massey C; Moat D; Sodhi J; Atalaia A; Gorman GS; Turner C; Lochmüller H
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1487-1497. PubMed ID: 31402614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscle force, balance and falls in muscular impaired individuals with myotonic dystrophy type 1: a five-year prospective cohort study.
    Hammarén E; Kjellby-Wendt G; Lindberg C
    Neuromuscul Disord; 2015 Feb; 25(2):141-8. PubMed ID: 25475393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rehabilitation interventions for foot drop in neuromuscular disease.
    Sackley C; Disler PB; Turner-Stokes L; Wade DT; Brittle N; Hoppitt T
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003908. PubMed ID: 19588347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A longitudinal physical profile assessment of skeletal muscle manifestations in myotonic dystrophy.
    Nitz JC; Burns YR; Jackson RV
    Clin Rehabil; 1999 Feb; 13(1):64-73. PubMed ID: 10327099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 9-year follow-up study of the natural progression of upper limb performance in myotonic dystrophy type 1: A similar decline for phenotypes but not for gender.
    Raymond K; Levasseur M; Mathieu J; Desrosiers J; Gagnon C
    Neuromuscul Disord; 2017 Jul; 27(7):673-682. PubMed ID: 28527585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between muscle impairments, postural stability, and gait parameters assessed with lower-trunk accelerometry in myotonic dystrophy type 1.
    Bachasson D; Moraux A; Ollivier G; Decostre V; Ledoux I; Gidaro T; Servais L; Behin A; Stojkovic T; Hébert LJ; Puymirat J; Eymard B; Bassez G; Hogrel JY
    Neuromuscul Disord; 2016 Jul; 26(7):428-35. PubMed ID: 27234310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower limb muscle impairment in myotonic dystrophy type 1: the need for better guidelines.
    Petitclerc É; Hébert LJ; Desrosiers J; Gagnon C
    Muscle Nerve; 2015 Apr; 51(4):473-8. PubMed ID: 25399769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress.
    Koutsoulidou A; Kyriakides TC; Papadimas GK; Christou Y; Kararizou E; Papanicolaou EZ; Phylactou LA
    PLoS One; 2015; 10(4):e0125341. PubMed ID: 25915631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the Nine Hole Peg Test as a measure of dexterity in myotonic dystrophy type 1.
    Cutellè C; Rastelli E; Gibellini M; Greco G; Frezza E; Botta A; Terracciano C; Massa R
    Neuromuscul Disord; 2018 Nov; 28(11):947-951. PubMed ID: 30270126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrarater reliability and validity of outcome measures in myotonic dystrophy type 1.
    Knak KL; Sheikh AM; Andersen H; Witting N; Vissing J
    Neurology; 2020 Jun; 94(24):e2508-e2520. PubMed ID: 32457208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic muscle stimulation improves muscle function and reverts the abnormal surface EMG pattern in myotonic dystrophy: a pilot study.
    Chisari C; Bertolucci F; Dalise S; Rossi B
    J Neuroeng Rehabil; 2013 Aug; 10():94. PubMed ID: 23938156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative motor assessment in myotonic dystrophy.
    Mathieu J; Boivin H; Richards CL
    Can J Neurol Sci; 2003 May; 30(2):129-36. PubMed ID: 12774952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2 : a whole body highfield MRI study.
    Kornblum C; Lutterbey G; Bogdanow M; Kesper K; Schild H; Schröder R; Wattjes MP
    J Neurol; 2006 Jun; 253(6):753-61. PubMed ID: 16511650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.